Background Despite wide availability of treatment options for hepatocellular carcinoma
(HCC), several studies have suggested underutilisation in clinical practice. Aims To quantify …

Objectives Less than 1 in 5 patients receive hepatocellular carcinoma surveillance;
however, most studies were performed in racially and socioeconomically homogenous …

Background Direct‐acting anti‐virals (DAA) are safe, effective treatment of hepatitis C virus
(HCV). Suboptimal linkage to specialists and access to DAA s are the leading barriers to …

The effect of hepatitis B virus (HBV) coinfection in patients with hepatitis C virus (HCV)
remains unclear. We used the National Veterans Affairs HCV Clinical Case Registry to …

Background. Direct acting antiviral agents (DAA) are highly effective yet expensive.
Disparities by race and/or gender often exist in the use of costly medical advances as they …

Low‐income populations are disproportionately affected by hepatitis C virus (HCV) infection.
Thus, implementing baby boomer screening (born 1945‐1965) for HCV may be a high …

Background Evidence-based guidelines and quality indicators for cirrhosis care have been
established. Whether there are variations in adherence to these cirrhosis standards at …

Background and Objectives: Direct-acting antiviral agents (DAA) are a safe and highly
effective treatment for hepatitis C virus (HCV) infection. However, the uptake of DAA …

Background: To help broaden the use of machine-learning approaches in health services
research, we provide an easy-to-follow framework on the implementation of random forests …

BACKGROUND & AIMS: Process of care–based measures are used commonly to assess
the quality of medical care provided to patients with chronic hepatitis C virus (HCV) infection …